Results 1 to 10 of about 12,297 (185)
The Therapy of Vulvar Carcinoma-Evaluation of Surgical Options in a Retrospective Monocentric Study. [PDF]
(1) Background: Surgical-oncological treatment methods are continuously put to the test in times of evidence-based medicine—notably, a constant reevaluation remains key, especially for tumor entities with increasing incidence such as vulvar carcinoma. (2)
Jankowski P +7 more
europepmc +2 more sources
Recurrent herpes simplex virus mimicking vulvar carcinoma in patient with Human Immunodeficiency Virus: A case report. [PDF]
Patients with human immunodeficiency virus (HIV) are at increased risk for developing other gynecologic conditions, including herpes simplex virus (HSV) and vulvar intraepithelial neoplasia (VIN)/carcinoma.
McKean R +4 more
europepmc +2 more sources
WNL we never looked: vulvar carcinoma incidence after screening cutoff. [PDF]
The incidence of vulvar carcinoma increases with age, though elderly women receive less aggressive cancer therapies and fewer strategies aimed at cancer prevention.
Geisler AN, Ganz JE.
europepmc +2 more sources
HPV16 viral characteristics in primary, recurrent and metastatic vulvar carcinoma. [PDF]
Vulvar carcinoma is the fourth most common gynecological malignancy. Two separate carcinogenic pathways are suggested, where one is associated with the human papillomavirus (HPV) and HPV16 the most common genotype.The aim of this study was to evaluate ...
Lillsunde Larsson G +4 more
europepmc +2 more sources
Time trends in human papillomavirus prevalence and genotype distribution in vulvar carcinoma in Norway. [PDF]
Introduction Approximately 25%–43% of all vulvar carcinomas are associated with human papillomavirus (HPV). In many countries, vulvar carcinoma incidence rates are increasing, possibly due to greater HPV exposure.
Meltzer-Gunnes CJ +6 more
europepmc +2 more sources
Background Vulvar neuroendocrine carcinomas with small cell morphology need an appropriate differential diagnosis with respect to primary Merkel cell carcinomas, primary small cell neuroendocrine carcinomas, and secondary/metastatic carcinomas.
Tomoko Hirakawa +4 more
doaj +1 more source
Pembrolizumab in FIGO IVB Verrucous Carcinoma of the Vulva: A Case Report
BackgroundVulvar cancer is the fourth most common gynecologic cancer, and prognosis is poor in advanced vulvar cancer patients. Treatment for advanced vulvar cancer has not been satisfactory.
Yuhan Wang +6 more
doaj +1 more source
Therapeutic Approaches to Vulvar Cancer: A Review of Literature
Objective: Vulvar cancer is a rare gynecological cancer that mainly affects postmenopausal women. The aim of this review is to analyze the most recent data available in the literature on the clinical and therapeutic approach to vulvar carcinoma ...
Tullio Golia D'Augè +13 more
doaj +1 more source
CONTEXT: Vulvar cancers are rare gynecologic tumors. Ultrasound can characterize primary tumors and guide the biopsy of suspicious nodes. Currently, there are no studies on the sonologic features of different vulvar cancer types.
Ma. Patricia Grace O. Siao +1 more
doaj +1 more source
Vulvar cancer is a malignancy of female lower genital tract with incidence of 1:100,000 in Poland. The most common types of vulvar cancers are squamous cell carcinoma and basal cell carcinoma.
Michał Migda +3 more
doaj +1 more source

